Leadership

A team with a track record of commercializing breakthroughs

Synthetic Genomics Inc. is a synthetic biology company founded to commercialize genomic-driven technologies. Our strength lies in the decades of pioneering research by our founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific, technology and business teams they have assembled. Our team has a proven track record of making scientific breakthroughs that translate into viable commercial solutions.

Oliver Fetzer, Ph.D., MBA

Chief Executive Officer

J. Craig Venter, Ph.D.

Co-Founder, Chairman, Co-Chief Scientific Officer

Hamilton O. Smith, M.D.

Co-Founder, Co-Chief Scientific Officer

Anthony Artuso, Ph.D.

Chief Business Officer

Rob Cutler

General Counsel, Corporate Secretary

Joseph Mahler

Chief Operating Officer, Chief Financial Officer

Todd Peterson, Ph.D.

Chief Technology Officer

Nathan Wood

Senior Vice President and President, SGI-DNA

Natasha O. Bowman

Vice President, Human Resources

Ben Chiarelli

Vice President of Corporate Development and Strategy

Dan Gibson, Ph.D.

Vice President, DNA Technology

Bolyn Hubby, Ph.D.

Vice President, Vaccines and Antimicrobials

Toby Richardson, Ph.D.

Vice President, Bioinformatics

Teresa Spehar

Vice President, Intellectual Property

Laurence Warden

Vice President, Engineering and Instrumentation
TOP